# Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder

> **NCT02294305** · PHASE4 · UNKNOWN · sponsor: **The Medical Research Network** · enrollment: 40 (estimated)

## Conditions studied

- Social Anxiety Disorder
- Major Depressive Disorder

## Interventions

- **DRUG:** Vortioxetine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02294305
- **Lead sponsor:** The Medical Research Network
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2016-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02294305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02294305, "Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02294305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*